BioTel Research Blog
BTR_Cardiac_Testing_headerBG.jpg

BioTel Research Blog

Fariba Ahdoot

Fariba Ahdoot is the marketing strategist at BioTelemetry Research.
Find me on:

Recent Posts

Archived Webinar: Body Composition in Clinical Trials – From BMI to MRI

Posted by Fariba Ahdoot on January 16, 2018
According to the WHO, obesity is an epidemic that kills at least 2.8 million people each year.  The number of obese children and adolescents worldwide has risen tenfold in the past four decades. Obesity is a major risk factor for heart disease, stroke, osteoarthritis, diabetes, liver disease such as non-alcoholic steatohepatitis (NASH), and certain cancers. Muscular dystrophies, such as Duchenne, ...
Read More

Topics: Imaging Science

Archived Webinar: Key Takeaways from the New CSRC/FDA Meeting on Cardiac Safety and Cardiovascular Safety Issues in Oncology Drug Development.

Posted by Fariba Ahdoot on October 11, 2017
On October 24-25, 2017 scientific experts gathered at the Cardiac Safety Research Consortium (CSRC)/FDA Annual Meeting to discuss cardiac risk management and safety assessment in oncology drug development. BioTelemetry Research’s Chief Medical Officer, Polina Voloshko, MD, and Vice President and Medical Director, Daniel Goodman, MD, attended the annual meeting and presented a complimentary ...
Read More

Topics: Cardiac Safety

Archived Webinar: Optimize the Imaging in Clinical Trials by Aligning Operational Excellence and Scientific Expertise

Posted by Fariba Ahdoot on August 02, 2017
The purpose of most clinical trials really boils down to a single question: Does my drug work? If you're feeling really ambitious, you may add a second question: How does my drug work? Medical imaging is one important tool for answering these questions, but imaging can be complicated, and mistakes are sometimes made. When things go wrong between you and your imaging provider, it's not easy to ...
Read More

Topics: Imaging Science

NASH Webinar Q&A: Discover the Non-invasive Techniques

Posted by Fariba Ahdoot on April 25, 2017
As part of our ongoing webinar series, we recently broadcasted Assessing NASH: Discover the Non-invasive Techniques, presented by Richard Ehman, M.D. from the Mayo Clinic and Jonathan Riek, Ph.D., Vice President, Musculoskeletal and Metabolic Imaging at BioTelemetry Research.  This webinar discussed noninvasive ways to assess NASH using imaging; for example, proton density fat fraction (PDFF), T1 ...
Read More

Topics: Imaging Science

Cardiovascular Effects within Cancer Therapies and Drug Development

Posted by Fariba Ahdoot on November 29, 2016
Cancer survivors in the United States, totaling nearly 15 million people, continue to face challenges following remission. These challenges include the risk of cancer recurrence and cardiovascular comorbidities that can manifest during and after cancer therapy. A recent article published by the New England Journal of Medicine, outlines the impact of cancer therapies on cardiovascular function and ...
Read More

Topics: Cardiac Safety

BioTel Research, One Preserve Parkway, Suite #600, Rockville, MD 20852